Cargando…
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
Autores principales: | Sora, Federica, Giammarco, Sabrina, Raiola, Anna Maria, Di Grazia, Carmen, Bregante, Stefania, Gualandi, Francesca, Varaldo, Riccardo, Chiusolo, Patrizia, Sica, Simona, Laurenti, Luca, Innocenti, Idanna, Autore, Francesco, Metafuni, Elisabetta, Galli, Eugenio, Bacigalupo, Andrea, Angelucci, Emanuele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325705/ https://www.ncbi.nlm.nih.gov/pubmed/35882842 http://dx.doi.org/10.1038/s41408-022-00701-w |
Ejemplares similares
-
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021) -
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
por: Sora, Federica, et al.
Publicado: (2021) -
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
por: Galli, Eugenio, et al.
Publicado: (2022) -
Days Alive Outside Hospital and Readmissions in Patients Undergoing Allogeneic Transplants from Identical Siblings or Alternative Donors
por: Sora, Federica, et al.
Publicado: (2020) -
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)